Viracta Therapeutics (VIRX)
(Delayed Data from NSDQ)
$0.22 USD
0.00 (-0.27%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $0.22 0.00 (-1.70%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.21 | 0.00% |
Earnings Summary
For their last quarter, Viracta Therapeutics (VIRX) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.35 per share. This reflects a positive earnings surprise of 28.57%. Look out for VIRX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 36.36%.
Earnings History
Price & Consensus
Zacks News for VIRX
Has IMARA (IMRA) Outpaced Other Medical Stocks This Year?
VIRX: What are Zacks experts saying now?
Zacks Private Portfolio Services